Clinical Trials Browser

Phase 2 × Lymphoma, Extranodal NK-T-Cell × tofacitinib × Clear all

NCT03598959 2018-07-26

Tofacitinib Combined With Chidamide in R/R ENKTCL

Phase 2 Unknown

Lymphoma, Extranodal NK-T-Cell